THE MANIPULATION OF IMMUNE PROCESSES WITH HETEROCROSSLINKED ANTIBODIES
THE MANIPULATION OF IMMUNE PROCESSES WITH HETEROCROSSLINKED ANTIBODIES
批准号:
3939230
负责人:
D M SEGAL
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
T lymphocyte antiantibody antibody specificity antitumor antibody blocking antibody cell aggregation cell population study clone cells crosslink cytolysis flow cytometry histocompatibility antigens human tissue immunoconjugates interleukin 2 major histocompatibility complex monoclonal antibody neoplasm /cancer immunotherapy neoplastic cell ovary neoplasms radiotracer spleen surface antigens
中文摘要
1.以抗T3和抗FCR为靶点的人T细胞和K细胞
异种交叉连接的抗肿瘤抗体已被根除
裸鼠体内的人卵巢癌细胞。
2.含抗A抗体的异交联体抗体
与细胞表面抗体相连的可溶性抗原
抗原提呈细胞(APC)上的决定簇,大大增强
抗原呈递的效率。增强了演示文稿
当抗原被靶向Fc受体表面时被看到
免疫球蛋白、MHC I类和MHC II类分子
APC。靶向抗原呈递是抗原特异性的,而且是I-A
有限制。
英文摘要
1. Human T cells and K cells targeted with anti-T3 and anti-FcR,
heterocrosslinked to anti-tumor antibodies eradicate established
human ovarian cancer cells in nude mice.
2. Heterocrosslinked antibodies containing an antibody against a
soluble antigen linked to an antibody against a cell surface
determinant on an antigen presenting cell (APC), greatly enhance
the efficiency of antigen presentation. Enhance presentation has
been seen when antigen was targeted to Fc receptors, surface
immunoglobulin, MHC class I and MHC class II molecules on the
APC. Targeted antigen presentation is antigen specific and I-A
restricted.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TARGETED CELLULAR CYTOTOXICITY
-
批准号:3813455
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:D M SEGAL
-
依托单位:
ACTIVATION AND TRIGGERING OF CYTOXIC CELLS
-
批准号:2463758
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:D M SEGAL
-
依托单位:
ACTIVATION AND TRIGGERING OF CYTOXIC CELLS
-
批准号:6161049
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:D M SEGAL
-
依托单位:
TARGETED CELLULAR CYTOTOXICITY
-
批准号:3796538
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:D M SEGAL
-
依托单位:
IMMUNOLOGICALLY RELEVANT CELL SURFACE PHENOMENA
-
批准号:3962941
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:D M SEGAL
-
依托单位:
TARGETED CELLULAR CYTOTOXICITY
-
批准号:3752089
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:D M SEGAL
-
依托单位:
TARGETED CELLULAR CYTOTOXICITY
-
批准号:3774386
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:D M SEGAL
-
依托单位:
TARGETED CELLULAR CYTOTOXICITY
-
批准号:3808592
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:D M SEGAL
-
依托单位:
STUDIES OF IMMUNOLOGICALLY RELEVANT CELL SURFACE PHENOMENA
-
批准号:4691756
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:D M SEGAL
-
依托单位:
TARGETED CELLULAR CYTOTOXICITY
-
批准号:5201004
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:D M SEGAL
-
依托单位:
ACTIVATION AND TRIGGERING OF CYTOXIC CELLS
-
批准号:6100949
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:D M SEGAL
-
依托单位:
MANIPULATION OF IMMUNE PROCESSES WITH HETEROCROSSLINKED ANTIBODIES
-
批准号:3916401
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:D M SEGAL
-
依托单位: